Two classes of receptors have been identified that mediate activation of the Ras/Mitogen Activated Protein Kinase (MAPK) pathway in response to extracellular signals, receptor protein-tyrosine kinases (PTKs) and heterotrimeric G-protein coupled receptors (GPCRs) (1) . It has been established that recruitment of the guanine nucleotide exchange factor for the Ras GTPase, Son of Sevenless, to the membrane is the activating step in the mechanism of receptor PTKmediated activation of MAPK. In this respect relatively little is known about how GPCRs couple to MAPK.
Lysophosphatidic acid (LPA) is the ligand for a putative GPCR and it is the prototypic GPCR agonist that activates the Ras/MAPK pathway (2) . The LPA receptor couples to at least three distinct heterotrimeric G proteins, G q , G 12/13 and G i . Pertussis toxin-sensitive G i induces Ras.GTP accumulation, eventually leading to MAPK activation, which is mediated by a PTK (3) . The identity of the PTKs that are involved in GPCRinduced MAPK activation is currently under debate.
Candidate PTKs that have been identified to link GPCRs to MAPK include cytoplasmically localized PTKs, Src, Lyn, Syk, Pyk2 and a receptor PTK, Epidermal Growth Factor Receptor (EGFR). Activation of these PTKs is dependent on the GPCR and appears to be cell-type specific. For instance, the Src-family PTK Lyn is essential for m1, but not m2 muscarinic acetylcholine receptor-induced MAPK activation, while the PTK Syk is necessary for both (4) . Src is activated in response to LPA and mediates MAPK activation in COS-7 and PC12 cells (5, 6) , but not in fibroblasts, since MAPK is still activated in Src -/-fibroblasts in response to LPA (7) . In PC12 cells, Src cooperates with Pyk2 in linking GPCRs, including receptors for bradykinin and LPA, to MAPK activation (6) . The EGFR has been found to link GPCR-activation to MAPK activation, since LPA-, ET-1-and thrombin-induced MAPK activation is blocked by an EGFR selective PTK inhibitor and by overexpression of dominant negative EGFR (8) . EGFR tyrosine phosphorylation (transactivation) may be involved in GPCR-induced MAPK activation (8) . However, other reports indicate that EGFR tyrosine phosphorylation is not induced in response to GPCR activation (6, 7) . Therefore, the mechanism by which the EGFR is involved in GPCR-mediated MAPK activation remains to be determined definitively.
Here we report that LPA and ET-1 did not induce MAPK activation in SK-N-MC cells. However, SK-N-MC cells were responsive to these ligands, in that LPA and ET-1 induced a rapid, transient increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ). Transient transfection of the EGFR into SK-N-MC cells potentiated LPA-and ET-1-induced MAPK activation, but LPA and ET-1 did not enhance basal level EGFR tyrosine phosphorylation. Our results demonstrate that introduction of the EGFR is sufficient to potenti-ate GPCR-induced MAPK activation in these cells, bolstering the idea that the EGFR is involved in GPCRinduced MAPK activation.
EXPERIMENTAL PROCEDURES
Cells, plasmids, and materials. SK-N-MC neuroepithelioma cells and COS-7 cells were cultured in a 1:1 mixture of DMEM and Ham's F12 (DF) medium supplemented with 10% and 7.5% foetal calf serum, respectively. The SV40-driven expression vector for the human EGFR, pSV2HERc, has been described before (9) . The cytomegalovirus (CMV) promoter driven expression vector for haemagglutinin (HA)-epitope-tagged p42 MAPK (10) Transient transfections and MAPK activity assays. Transient transfections by calciumphosphate precipitation were done exactly as described before (11) . Following stimulation with the indicated stimuli for 5 min, the cells were lysed in cell lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1% Triton X-100, 10% glycerol, 10 u/ml aprotinin, 1 M pMSF, 200 M sodium orthovanadate). Immunoprecipitation was done by incubation with anti HA-tag MAb (12CA5) and protein A-sepharose (Pharmacia, Uppsalala, Sweden) for 3 h at 4°C. The beads were washed extensively and resuspended in kinase buffer (40 mM Tris pH 8.0, 20 mM MgCl 2 , 2 mM MnCl 2 , 10 M ATP) containing 1 Ci ␥-[ 32 P]-ATP and 10 g myelin basic protein (MBP) as a substrate per sample and incubated for 30 min at 30°C, followed by addition of Laemmli sample buffer, boiling and loading on 15% SDS-polyacrylamide gels. The kinase assays were quantified using a Phosphorlmager (Molecular Dynamics) and visualized by autoradiography.
[Ca 2ϩ ] i measurements. SK-N-MC cells, attached to a glass substrate, were incubated in Hepes buffered saline (HBS: 10 mM HEPES, 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, pH 7.3 at 33°C) with 10 M Indo-1-AM (Molecular Probes, OR, USA) for 45 min. Coverslips were mounted in a quartz cuvette and measurements were done using a Perkin Elmer model LS50B fluorescence spectrometer at 33°C (excitation 355 nm [slit 5 nm] and 405 nm emission [slit 10 nm]). Calibration of the internal calcium was determined using 5 g/ml ionomycin. The maximal and minimal fluorescence was determined by addition of 4 mM CaCl 2 , and 6 mM MnCl 2 , respectively in the presence of ionomycin. Absolute values were calculated according to Grynkiewitcz et al. (12) .
Immunoprecipitation and immunoblotting. The EGFR was immunoprecipitated using MAb 108.1 (13) . Immunoblotting was done exactly as described before (11), using anti-P.Tyr MAb PY-20 (Transduction Laboratories, KY, USA) or polyclonal rabbit anti-EGFR antibody 281-7 (14) (kind gift of Bas Defize). Detection of the immunoreactive bands using horse radish peroxidase-conjugated secondary antibodies was done by enhanced chemiluminescence (ECL).
RESULTS

Lack of MAPK activation in response to LPA in SK-N-MC cells.
We investigated MAPK activation in response to a panel of stimuli in SK-N-MC neuroepithelioma cells. The cells were transiently transfected with epitope-tagged MAPK (HA-MAPK), stimulated for 5 min with LPA, FGF or EGF, and MAPK activity was determined by a kinase assay, using myelin basic protein (MBP) as a substrate. Whereas FGF induced a 15-to 25-fold stimulation of MAPK activity, LPA nor EGF elicited detectable MAPK activation in these cells (Figure 1) . SK-N-MC cells are not responsive to EGF, since these cells do not express endogenous EGFRs (15, 16) . In parallel to the SK-N-MC cells we determined MAPK activation in response to the same panel of stimuli in COS-7 cells. All three stimuli induced strong MAPK activation (8-to 14-fold), depending on the stimulus (Figure 1 ). These results demonstrate that SK-N-MC cells are not responsive to LPA with respect to MAPK activation. Relative MAPK activation varied from experiment to experiment, presumably due to subtle differences in experimental conditions. However, LPA and ET-1 always induced significant MAPK activation in EGFRtransfected cells, but never in mock-transfected cells. The response to PDGF (13-to 45-fold MAPK activation) was not dependent on co-transfection of the EGFR (Figure 3) . The EGFR is functional in transiently transfected SK-N-MC cells, since EGF itself also induced MAPK-activation (32-to 62-fold) in EGFRtransfected, but not mock-transfected cells. These results demonstrate that overexpression of the EGFR potentiated GPCR-induced MAPK activation in SK-N-MC cells.
LPA-and ET-1-induced Ca
LPA and ET-1 did not induce EGFR transactivation in SK-N-MC cells.
Whether GPCR activation induces EGFR tyrosine phosphorylation (transactivation) is currently under debate (6 -8, 19) . In order to establish whether LPA and ET-1 induced EGFR transactivation in SK-N-MC cells, we determined EGFR tyrosine phosphorylation by immunoblotting. Transient transfection of the EGFR in SK-N-MC cells resulted in low basal level tyrosine phosphorylation of the EGFR. LPA nor ET-1 induced enhanced EGFR tyrosine phosphorylation, while EGF elicited a robust increase in EGFR tyrosine phosphorylation (Figure 4 ). These results demonstrate that transiently transfected EGFR is functional and suggest that LPA-and ET-1-induced MAPK activation in transiently transfected SK-N-MC cells is not due to EGFR transactivation.
DISCUSSION
Activation of GPCRs induces activation of MAPK via an intermediary PTK. Identification of this intermedi-
FIG. 3.
The EGFR potentiated MAPK activation in response to GPCR activation. SK-N-MC cells were transiently co-transfected with HA-epitope-tagged MAPK and expression vector (Mock) or pSV2HERc, an expression vector for the human EGFR. The cells were serum-starved overnight and left untreated, or they were treated with LPA (1 M), ET-1 (100 nM), EGF (50 ng/ml), or PDGF (50 ng/ml) for 5 min. Subsequently, the cells were lysed, epitopetagged MAPK was immunoprecipitated, and a kinase assay was performed, using MBP as a substrate. Equal HA-MAPK expression was monitored by immunoblotting (data not shown) and MAPKactivity was determined using a Phosphorlmager. MAPK activation is depicted as fold induction, relative to the mock-transfected or EGFR-transfected unstimulated controls, respectively. ary PTK has been the subject of several recent studies and at least five PTKs have been found that may mediate GPCR-induced MAPK activation. Here we provide evidence supporting the model that the EGFR, one of the candidate PTKs, is involved in MAPK activation in response to LPA and ET-1, since transfection of the EGFR in SK-NM-C cells, that lack endogenous EGFR, potentiates MAPK activation by these two GPCR agonists.
The mechanism by which GPCR activation leads to MAPK activation remains to be determined definitively. LPA is the prototypic GPCR ligand that induces MAPK activation. The LPA receptor mediates its effects through at least three distinct heterotrimeric G proteins, G q , G 12/13 and G i (2) . G 12/13 may link the LPA receptor to the small GTP-binding protein Rho, eventually leading to cytoskeletal remodelling and cell shape changes (20, 21) . G q links to phospholipase C␤, leading to the production of diacylglycerol and inositol tris-phosphate (IP 3 ), resulting in activation of Protein Kinase C (PKC) and Ca 2ϩ -mobilization, respectively (22) . It has been speculated that G q -mediated activation of PKC may lead to MAPK activation in a Rasindependent manner (1,23) . However, G q -mediated MAPK activation was only partially inhibited following downregulation of PKC, indicating that G q -mediated MAPK activation is largely PKC-independent (24). Moreover, pertussis toxin completely abolished LPAinduced MAPK activation in Rat-1 fibroblasts (25), indicating that LPA-induced MAPK activation is mediated solely by pertussis toxin sensitive G i and not by G q . Here we demonstrate that LPA elicited a rise in [Ca 2ϩ ] i in SK-N-MC cells, which is presumably mediated by G q . However, LPA did not induce MAPK activation in these cells, suggesting that G q -activated pathways are not involved in MAPK activation in SK-N-MC cells.
G i -mediated MAPK activation is most likely mediated by the G i ␤␥ subunits, rather than the ␣ i subunit (5, 26, 27) , and involves an intermediary PTK, since genistein and staurosporine, non-specific inhibitors of PTK activity, abolished activation of the Ras/MAPK pathway (3, 7, 25, 28) . Several candidate PTKs have been identified that may mediate MAPK activation in response to GPCR agonists (4 -6,8) . The EGFR may link GPCRs to MAPK activation in Rat-1 fibroblasts, since LPA-, ET-1-and thrombin-induced MAPK activation was blocked by overexpression of dominant negative EGFR, and by an EGFR selective PTK-inhibitor (8) . More detailed analysis of the involvement of the EGFR in GPCR-mediated MAPK activation indicated that Src is involved as well, since the Src-specific inhibitor, PP1, severely inhibited LPA-and EGF-induced MAPK activation (19) . However, the involvement of Src in LPA-induced MAPK activation is complex, since MAPK activation was still observed in Src Ϫ/Ϫ cells (7). We demonstrate here that SK-N-MC cells are not responsive to LPA and ET-1 with respect to MAPK activation. Src immunoprecipitation/ kinase assays indicated that SK-N-MC cells express Src at levels that are comparable to fibroblasts (data not shown), suggesting that Src is not sufficient for LPA-and ET-1-induced MAPK activation. Overexpression of Src by itself induced MAPK activation which was not enhanced further by LPA or ET-1 (data not shown). Therefore, we cannot exclude the possibility that Src is involved in GPCR-induced MAPK activation via the EGFR in SK-N-MC cells.
Transient transfection of the EGFR in SK-N-MC cells potentiated LPA-and ET-1-induced MAPK activation. SK-N-MC cells do not express endogenous EGFR. However, these cells express functional receptor PTKs, including FGFR and PDGFR (15, 16 and Figures 1 and 3) . Apparently, endogenous FGFR and PDGFR do not mediate MAPK activation in response to GPCR agonists. It is noteworthy that dominant negative EGFR and specific EGFR inhibitors inhibited GPCR-induced MAPK activation (8, 19) , suggesting that the EGFR specifically mediates GPCR-induced MAPK activity.
Transient transfection of the EGFR in SK-N-MC cells led to low basal levels of EGFR autophosphorylation as determined by anti-P.Tyr immunoblotting, conceivably due to EGFR overexpression at relatively high levels (Figure 4 ). LPA and ET-1 did not induce en-hanced tyrosine phosphorylation of the EGFR, while EGF did, suggesting that establishment of GPCRinduced MAPK activation by transient transfection of the EGFR is not due to transactivation of the EGFR, as described in previous reports (8, 19) . Our data are consistent with several reports that fail to detect EGFR transactivation in response to GPCR activation (6, 7) . The mechanism by which the EGFR is involved in GPCR-induced MAPK activation in SK-N-MC cells remains to be determined. It is noteworthy that PDGFinduced MAPK activation, which is independent of EGFR-signalling, is similar in mock-transfected and EGFR transfected cells (Figure 3) , indicating that transient transfection of the EGFR by itself did not enhance MAPK activation in general. Transfection of the EGFR into SK-N-MC cells led to low basal level tyrosine phosphorylation of the EGFR itself (Fig. 4) , but did not induce major increases in tyrosine phosphorylation of cellular proteins (data not shown). LPA and ET-1 did not enhance EGFR tyrosine phosphorylation and we did not detect significant changes in tyrosine phosphorylation of cellular proteins, as determined by anti-P.Tyr immunoblotting of total cell lysates (data not shown). However, we cannot exclude the possibility that subtle changes in tyrosine phosphorylation are induced by LPA and ET-1. Transient transfection of the EGFR clearly potentiated GPCR-induced MAPK activation in SK-N-MC cells. Since transactivation apparently is not involved in GPCR-induced MAPK activation in SK-N-MC cells, we hypothesize that the basal level EGFR tyrosine phosphorylation that we observed may be sufficient to potentiate GPCR-induced MAPK activation, for instance by recruiting adaptor proteins and/or other signalling proteins to the membrane. Alternatively, basal level EGFR PTK activity may lead to subtle changes in P.Tyr-content of key substrates, thereby potentiating GPCR-induced MAPK activation.
Here we demonstrate that transient transfection of the EGFR potentiated GPCR-induced MAPK activation in SK-N-MC cells that are normally not responsive to GPCR-activation with respect to MAPK activation, bolstering the idea that the EGFR is involved in linking GPCRs to MAPK activation. Since transient transfection of the EGFR is sufficient to potentiate GPCRinduced MAPK activation in SK-NM-C cells, these cells may be a useful tool to dissect the mechanism of EGFRmediated GPCR-induced MAPK activation.
